Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Lutathera in Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Demonstrate Uptake on DOTATATE PET

NCT05278208 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT05278208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05278208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Lutathera in Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Demonstrate Uptake on DOTATATE PET
Lead sponsor
Nationwide Children's Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
November 21, 2022
Completion date
November 30, 2033
Enrollment
65 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic ependymoma, embryonal tumor, high grade glioma, medulloblastoma, meningioma, recurrent diffuse intrinsic pontine glioma, recurrent malignant glioma, recurrent medulloblastoma, recurrent primary central nervous system neoplasm, refractory diffuse intrinsic pontine glioma, refractory malignant glioma, refractory medulloblastoma, refractory primary central nervous system neoplasm